Drug Trial Radar · NCT01278433
A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China
Last checked: Nov 20, 2026Latest source record: Mar 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5,007
Actual
Start
Dec 2010
Primary completion
Dec 2011
Study completion Jun 2012
Sponsor
- Lead sponsor
- Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jan 17, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 60 days, up to 89 days
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The aim of the study is to collect post marketing safety data on IMOVAX Polio vaccine in China. Objective: To describe serious adverse events 30 days after each dose of IMOVAX Polio™ administered at 2, 3, and 4 months of age among infants living in the study cities of China.
Conditions
- Polio
- Poliomyelitis
Interventions
IMOVAX Polio™: Inactivated Poliomyelitis VaccineBiological
0.5 mL, Intramuscular
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants reporting serious adverse events and relationship to Imovax Polio vaccination.Time frame: Up to 30 days after each vaccination
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Changsha, China
Site not named
Chengdu, China
Site not named
Chongqing, China
Site not named
Hangzhou, China
Site not named
Jinan, China
Site not named
Kunming, China
Site not named
Nanjing, China
Site not named
Qingdao, China
Site not named
Shenyang, China
Site not named
Shenzhen, China
Site not named
Tianjin, China
Site not named
Wuhan, China
Site not named
Xi'an, China
Site not named
Zheng Zho, China
Site not named
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.